Study finds people with allergies have low risk of serious reaction to COVID-19 vaccines
Researchers found reassuring safety patterns in people with moderate to severe allergies following COVID-19 vaccination.
Researchers found reassuring safety patterns in people with moderate to severe allergies following COVID-19 vaccination.
A new study found that almonds are now a leading cause of tree nut–induced anaphylaxis in adults, despite traditionally been seen as low-risk.
A rare case of SM associated with a skin lymphoma was recently reported, and is the only known case of the lymphoma occurring with BMM.
Scientists found five genetic changes in people with systemic mastocytosis (SM), including two never reported before.
Researchers found allergen-specific treatment using mRNA technology prevented and even reversed allergic disease in mice.
Eosinophil, monocyte and leukocyte counts could correlate with the severity of systemic mastocytosis (SM) and predict outcomes.
A recent case report describes the specially tailored anesthetic protocol for a C-section in a woman with systemic mastocytosis (SM).
Stem cell transplantation can reduce disease activity for people with advanced systemic mastocytosis (SM) and may help patients live longer.
Aggressive systemic mastocytosis (SM) can present with nonspecific symptoms like fever, which can complicate diagnosis
The case highlights the challenges of diagnosing and treating both KIT-negative SM and SM with an associated hematologic neoplasm (SM-AHN).